Loading stock data…
SEER
$1.84-0.02 (-1.34%)
Market OpenUpdated 2:36 PM EDT
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Seer, Inc. in the Healthcare sector is trading at $1.84. The stock is currently 23% below its 52-week high of $2.41, remaining 6.8% below its 200-day moving average. Technical signals show neutral RSI of 37 and bearish MACD signal, explaining why SEER maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 37) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.84
Potential Upside
5%
Whystock Fair Value$1.94
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Pr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$111.71M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.60
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-28.38%
Volume
Today's trading volume
94,883
Recent News
How Seer (SEER) Is Rewriting Its Story With New Targets And Activist Pressure
Seer’s analyst price target has shifted from US$3.29 to US$4.00, changing the implied upside that some investors will be watching closely. Supportive analysts link this new US$4.00 level to updated assumptions on growth potential and profitability, while more cautious voices flag how much it relies on specific expectations being met. As you read on, you will see how this revised target fits into the latest activist activity and how to track the story as it develops. Analyst Price Targets...
Uncovering Opportunities: Penny Stocks To Watch In April 2026
Over the last 7 days, the United States market has experienced a significant downturn, dropping 29%, and is down 82% over the past year, though earnings are forecast to grow by 16% annually. In challenging market conditions like these, identifying stocks with strong financial fundamentals becomes crucial for investors seeking potential opportunities. Although "penny stocks" may seem like an outdated term, they continue to represent smaller or newer companies that can offer both affordability...
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks rose late Monday afternoon, with the NYSE Health Care Index up 0.2% and the State
Sector Update: Health Care Stocks Softer Monday Afternoon
Health care stocks declined Monday afternoon, with the NYSE Health Care Index down 0.2% and the Stat
Thermo Fisher Stock May Benefit Following Collaboration With PRECISE
TMO teams up with PRECISE on a major proteomics study, expanding its role in large biobank projects and precision medicine initiatives.